BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 892335)

  • 1. Serum glycoproteins in the liver diseases. IV. Alpha-1 acid glycoprotein level in liver cirrhosis.
    Arima T; Motoyama Y; Yamamoto T; Nagata K; Kondo T
    Gastroenterol Jpn; 1977; 12(2):43-6. PubMed ID: 892335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of serum ischemia-modified albumin for assessing liver function in patients with chronic liver disease.
    Chen CY; Tsai WL; Lin PJ; Shiesh SC
    Clin Chem Lab Med; 2011 Nov; 49(11):1817-21. PubMed ID: 21851314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum glycoproteins in the liver diseases. VIII. Desialylated glycoproteins in the liver cirrhosis.
    Arima T
    Gastroenterol Jpn; 1979 Aug; 14(4):349-52. PubMed ID: 488625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The binding rate of sialic acid to serum alpha 1-acid glycoprotein in patients with chronic hepatic injury.
    Ozeki T; Okada Y; Iwaki K
    Gastroenterol Jpn; 1987 Aug; 22(4):448-52. PubMed ID: 3311865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in serum alpha 1 antitrypsin, alpha1 acid glycoprotein and beta 2 glycoprotein I in patients with malignant hepatocellular carcinoma.
    Chio LF; Oon CJ
    Cancer; 1979 Feb; 43(2):596-604. PubMed ID: 84707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum 7 alpha-hydroxycholesterol as a new parameter of liver function in patients with chronic liver diseases.
    Kuroki S; Okamoto S; Naito T; Oda H; Nagase S; Sakai H; Nawata H; Yamashita H; Chijiiwa K; Tanaka M
    Hepatology; 1995 Oct; 22(4 Pt 1):1182-7. PubMed ID: 7557870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The serum protein profile in chronic hepatitis, cirrhosis and liver cancer.
    Hiramatsu S; Kojima J; Okada TT; Inai S; Ohmori K
    Acta Hepatogastroenterol (Stuttg); 1976 Jun; 23(3):177-82. PubMed ID: 60035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum glycoproteins in the liver diseases. II. Radioimmunoassay of alpha-1 acid glycoprotein.
    Arima T; Motoyama Y; Nagata K; Kondo T
    Gastroenterol Jpn; 1976; 11(4):307-12. PubMed ID: 1017593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The binding of indocyanine green and other organic anions to serum proteins in liver diseases.
    Kamisaka K; Yatsuji Y; Yamada H; Kameda H
    Clin Chim Acta; 1974 Jun; 53(2):255-64. PubMed ID: 4366883
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatocyte growth factor and acute phase proteins in patients with chronic liver diseases.
    Shiota G; Umeki K; Okano J; Kawasaki H
    J Med; 1995; 26(5-6):295-308. PubMed ID: 8721905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of serum procalcitonin levels in patients with acute or chronic liver disease.
    Elefsiniotis IS; Skounakis M; Vezali E; Pantazis KD; Petrocheilou A; Pirounaki M; Papatsibas G; Kontou-Kastellanou C; Moulakakis A
    Eur J Gastroenterol Hepatol; 2006 May; 18(5):525-30. PubMed ID: 16607149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interindividual variability in the concentrations of albumin and alpha-1-acid glycoprotein in patients with renal or liver disease, newborns and healthy subjects: implications for binding of drugs.
    Viani A; Rizzo G; Carrai M; Pacifici GM
    Int J Clin Pharmacol Ther Toxicol; 1992 Apr; 30(4):128-33. PubMed ID: 1572757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal reaction and serum glycoprotein concentration in chronic hepatitis and liver cirrhosis.
    Fehér J; Jakab L; Józsa L; Szilvási I; Papp G
    Acta Morphol Acad Sci Hung; 1975; 23(4):319-26. PubMed ID: 1234831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multivariate analysis of serum protein assays in chronic hepatitis and postnecrotic cirrhosis.
    Agostoni A; Marasini B; Stabilini R; Del Ninno E; Pontello M
    Clin Chem; 1974 Apr; 20(4):428-9. PubMed ID: 4544786
    [No Abstract]   [Full Text] [Related]  

  • 15. [The serum prealbumin significance in differential diagnosis of the liver diseases (author's transl)].
    Gróza S
    Med Klin; 1976 Feb; 71(9):378-9. PubMed ID: 1256337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum albumin and total globulin levels in common liver diseases in Accra (Ghana).
    Fenuku RI; Foli AK
    Trop Geogr Med; 1978 Mar; 30(1):87-90. PubMed ID: 209591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevation of serum type IV collagen in liver cancer as well as liver cirrhosis.
    Hong WS; Hong SI; Park SY; Son Y; Lee YS; Chung YH; Yang SK; Suh DJ; Min YI
    Anticancer Res; 1995; 15(6B):2777-80. PubMed ID: 8669863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum iron parameters in patients with alcoholic and chronic cirrhosis and hepatitis.
    Jurczyk K; Wawrzynowicz-Syczewska M; Boroń-Kaczmarska A; Sych Z
    Med Sci Monit; 2001; 7(5):962-5. PubMed ID: 11535942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Indicators of protein metabolism in chronic hepatitis and liver cirrhosis].
    Voloshchuk OA; Fedoruk SG; Rozgon GI; Andrievskaia SE; Kolbasova AN
    Vrach Delo; 1978 Dec; (12):74-7. PubMed ID: 743342
    [No Abstract]   [Full Text] [Related]  

  • 20. [Serum cathepsin activity in chronic liver diseases].
    Kucharz EJ; Kucharz M
    Z Gesamte Inn Med; 1986 Nov; 41(22):636-8. PubMed ID: 3031888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.